Clinical Trial Update: "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER- [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing pharmacodynamic effects of omeprazole versus pantoprazole on platelet reactivity in patients with acute coronary syndrome on du…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Prilosec (omeprazole) (omeprazole)
• Protonix (pantoprazole) (pantoprazole)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN